Regarding transcription factors, the two tumor-specific CD8+T subsets expressed comparable Eomes and TOX, while PD-1+CXCR5+CD8+T cells show higher T-bet and TCF7 expression (Fig. 5j). This evidence concerns the gene CD8A and neoplasm.